Amalgamation of Organ-on-Chip with Organoids to be a Prevalent Trend in the Organoids Market
According to a new market research study of ‘Asia-Pacific Organoids Market to 2027 - Regional Analysis and Forecasts by Type, Application, and Source,’ the Asia-Pacific organoids market is expected to reach US$ 513.74 Mn in 2027 from US$ 97.02 Mn in 2019. The market is estimated to grow with a CAGR of 23.1% from 2020-2027. The report provides trends prevailing in the Asia-Pacific organoids market and the factors driving market along with those that act as hindrances.
Organoid and organ-on-a-chip, which are served as evolving pathological and human physiological relevant in vitro models, hold an excessive potential to revolutionize the conventional example in basic and clinical research. The recent inclination in the collaborative application of organoid with organ-on-a-chip and 3D bio printing enables development of sophisticated cancer models to study underlying mechanisms of tumour-stroma interactions, multi-organ tumour metastasis, and cancer-microenvironment interactions. By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit both organoid and organ-on-a-chip benefits and provides a useful tool to study multi-organ tumour metastases and cancer-microenvironment interactions. Overall, researchers expect that these emerging in vitro cancer model systems will ultimately revolutionize the conventional paradigm of cancer research and produce real clinical benefits.
Key driving factor such as rising adoption of bio-banking and tumour modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the market. However, lack of expertise is likely to have a negative impact on the growth of the market in the coming years.
THERMO FISHER SCIENTIFIC, INC., Merck KGaA, CORNING INCORPORATED, STEMCELL Technologies, Inc., and Organoid Therapeutics are some of the leading companies operating in the Asia-Pacific organoids market.
The report segments Asia-Pacific Organoids Market as follows:
Asia-Pacific Organoids Market- By Type
Asia-Pacific Organoids Market- By Application
Asia-Pacific Organoids Market - By End User
Asia-Pacific Organoids Market- By Geography
Reasons to Buy
According to a new market research study of ‘Asia-Pacific Organoids Market to 2027 - Regional Analysis and Forecasts by Type, Application, and Source,’ the Asia-Pacific organoids market is expected to reach US$ 513.74 Mn in 2027 from US$ 97.02 Mn in 2019. The market is estimated to grow with a CAGR of 23.1% from 2020-2027. The report provides trends prevailing in the Asia-Pacific organoids market and the factors driving market along with those that act as hindrances.
Organoid and organ-on-a-chip, which are served as evolving pathological and human physiological relevant in vitro models, hold an excessive potential to revolutionize the conventional example in basic and clinical research. The recent inclination in the collaborative application of organoid with organ-on-a-chip and 3D bio printing enables development of sophisticated cancer models to study underlying mechanisms of tumour-stroma interactions, multi-organ tumour metastasis, and cancer-microenvironment interactions. By incorporating multiple organoids into organ-on-a-chip, organoid-on-a-chip can inherit both organoid and organ-on-a-chip benefits and provides a useful tool to study multi-organ tumour metastases and cancer-microenvironment interactions. Overall, researchers expect that these emerging in vitro cancer model systems will ultimately revolutionize the conventional paradigm of cancer research and produce real clinical benefits.
Key driving factor such as rising adoption of bio-banking and tumour modelling and alternatives for animal testing models acting as kingpins are expected to augment the growth of the market. However, lack of expertise is likely to have a negative impact on the growth of the market in the coming years.
THERMO FISHER SCIENTIFIC, INC., Merck KGaA, CORNING INCORPORATED, STEMCELL Technologies, Inc., and Organoid Therapeutics are some of the leading companies operating in the Asia-Pacific organoids market.
The report segments Asia-Pacific Organoids Market as follows:
Asia-Pacific Organoids Market- By Type
- Stomach
- Intestine
- Liver
- Pancreas
- Lung
- Brain
- Kidney
- Others
Asia-Pacific Organoids Market- By Application
- Developmental Biology
- Disease Pathology of Infectious Disease
- Regenerative Medicine
- Drug Toxicity and Efficacy Testing
- Drug Discovery and Personalized Medicine
- Others
Asia-Pacific Organoids Market - By End User
- Pluripotent Stem Cells
- Organ-specific Adult Stem Cells
Asia-Pacific Organoids Market- By Geography
- Asia-Pacific
- India
- China
- South Korea
- Japan
- Australia
Reasons to Buy
- To understand the organoids market landscape and identify market segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape for organoids market.
- Efficiently plan M&A and partnership deals in organoids market by identifying market segments with the most promising probable sales.
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form organoids market.
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia-Pacific region.
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Organoids Market Landscape
5. Asia Pacific Organoids Market - Key Market Dynamics
6. Organoids Market - Asia Pacific Analysis
7. Organoids Market - By Type
8. Organoids Market Analysis - By Application
9. Organoids Market Analysis - By Source
10. Organoids Market Revenue and Forecasts To 2027 - Geographical Analysis
11. Impact of COVID-19 Pandemic on Asia-Pacific Organoids Market
12. Company Profiles
13. Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- THERMO FISHER SCIENTIFIC INC
- Merck KGaA
- STEMCELL Technologies Inc
- Organoid Therapeutics
- Corning Incorporated
